other names for retatrutide vs. Tirzepatide: The New Contender vs. the Current Leader Company linked to raid on

They are a helpful piece of the puzzle, but rarely the entire answer

Not only does off-label prescribing make it difficult for people with diabetes to continue using Ozempic without interruption, but it may also deter providers from starting new diabetic patients on Ozempic out of concern that access to the drug will be inconsistent

A break and restart in GLP-1 agonist use near the time of surgery could theoretically present a significantly higher risk of aspiration compared to uninterrupted use

Focus on lean proteins, non-starchy vegetables, and soluble fiber sources like oats and legumes in small portions

Additionally, in Europe, the European Medicines Agency (EMA) approved Wegovy in 2022, and countries such as the UK have integrated it into national obesity programs, where demand far exceeded supply in 2024 (MHRA)